Literature DB >> 11904393

Dissociation of peripheral T cell responses from thymocyte negative selection by weak agonists supports a spare receptor model of T cell activation.

Lisa K McNeil1, Brian D Evavold.   

Abstract

We have focused on stability of the peptide-MHC complex as a determining factor of ligand potency for thymocytes and peripheral CD4+ T cell responses. MHC variant peptides that have low affinities and fast dissociation rates are different in that they stimulate proliferation and cytolysis of mature T cells (classifying the variant peptides as weak agonists) but do not induce thymocyte negative selection. The MHC variant weak agonists require significant receptor reserve, because decreasing the level of T cell receptor on mature T cells blocks the proliferative response. These results demonstrate that peripheral T cells are more sensitive to MHC variant ligands by virtue of increased T cell receptor expression; in addition, the data support a T cell model of the spare receptor theory.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11904393      PMCID: PMC123680          DOI: 10.1073/pnas.072673899

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

1.  Complete dissection of the Hb(64-76) determinant using T helper 1, T helper 2 clones, and T cell hybridomas.

Authors:  B D Evavold; S G Williams; B L Hsu; S Buus; P M Allen
Journal:  J Immunol       Date:  1992-01-15       Impact factor: 5.422

Review 2.  T cell receptor antagonists and partial agonists.

Authors:  S C Jameson; M J Bevan
Journal:  Immunity       Date:  1995-01       Impact factor: 31.745

Review 3.  Positive selection of thymocytes.

Authors:  S C Jameson; K A Hogquist; M J Bevan
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

4.  Kinetic proofreading in T-cell receptor signal transduction.

Authors:  T W McKeithan
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

5.  Kinetics of T-cell receptor binding to peptide/I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness.

Authors:  K Matsui; J J Boniface; P Steffner; P A Reay; M M Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

6.  Negative selection of CD4+ CD8+ thymocytes by T-cell receptor peptide antagonists.

Authors:  D M Page; J Alexander; K Snoke; E Appella; A Sette; S M Hedrick; H M Grey
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

7.  Kinetics and affinity of reactions between an antigen-specific T cell receptor and peptide-MHC complexes.

Authors:  Y Sykulev; A Brunmark; M Jackson; R J Cohen; P A Peterson; H N Eisen
Journal:  Immunity       Date:  1994-04       Impact factor: 31.745

8.  Serial triggering of many T-cell receptors by a few peptide-MHC complexes.

Authors:  S Valitutti; S Müller; M Cella; E Padovan; A Lanzavecchia
Journal:  Nature       Date:  1995-05-11       Impact factor: 49.962

9.  Low avidity recognition of self-antigen by T cells permits escape from central tolerance.

Authors:  G Y Liu; P J Fairchild; R M Smith; J R Prowle; D Kioussis; D C Wraith
Journal:  Immunity       Date:  1995-10       Impact factor: 31.745

10.  Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II.

Authors:  A Sette; S Southwood; J Miller; E Appella
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

View more
  12 in total

Review 1.  Defining the parameters necessary for T-cell recognition of ligands that vary in potency.

Authors:  Neely E Kilgore; Mandy L Ford; Carrie D Margot; Daniel S Jones; Peter Reichardt; Brian D Evavold
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

2.  Type 1 diabetes associated HLA-DQ2 and DQ8 molecules are relatively resistant to HLA-DM mediated release of invariant chain-derived CLIP peptides.

Authors:  Zemin Zhou; Eduardo Reyes-Vargas; Hernando Escobar; Brant Rudd; Alan L Rockwood; Julio C Delgado; Xiao He; Peter E Jensen
Journal:  Eur J Immunol       Date:  2016-01-22       Impact factor: 5.532

3.  New concept of spare receptors and effectors.

Authors:  Y Marunaka; N Niisato; H Miyazaki
Journal:  J Membr Biol       Date:  2005-01       Impact factor: 1.843

Review 4.  Manipulating antigenic ligand strength to selectively target myelin-reactive CD4+ T cells in EAE.

Authors:  Joseph J Sabatino; Kristen M Rosenthal; Brian D Evavold
Journal:  J Neuroimmune Pharmacol       Date:  2009-11-11       Impact factor: 4.147

Review 5.  T cell antigen recognition at the cell membrane.

Authors:  Jun Huang; Christina Meyer; Cheng Zhu
Journal:  Mol Immunol       Date:  2012-06-07       Impact factor: 4.407

6.  Peptide-MHC class II complex stability governs CD4 T cell clonal selection.

Authors:  Christina K Baumgartner; Andrea Ferrante; Mika Nagaoka; Jack Gorski; Laurent P Malherbe
Journal:  J Immunol       Date:  2009-12-09       Impact factor: 5.422

7.  Without peripheral interference, thymic deletion is mediated in a cohort of double-positive cells without classical activation.

Authors:  Yifan Zhan; Jared F Purton; Dale I Godfrey; Timothy J Cole; William R Heath; Andrew M Lew
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-21       Impact factor: 11.205

8.  Destabilization of peptide:MHC interaction induces IL-2 resistant anergy in diabetogenic T cells.

Authors:  Lindsay J Edwards; Brian D Evavold
Journal:  J Autoimmun       Date:  2013-07-26       Impact factor: 7.094

9.  NFM Cross-Reactivity to MOG Does Not Expand a Critical Threshold Level of High-Affinity T Cells Necessary for Onset of Demyelinating Disease.

Authors:  Lori Blanchfield; Joseph J Sabatino; Laurel Lawrence; Brian D Evavold
Journal:  J Immunol       Date:  2017-09-08       Impact factor: 5.422

10.  Search for adenosine A2A spare receptors on peripheral human lymphocytes.

Authors:  Laurent Jacquin; Frédéric Franceschi; Youlet By; Josée-Martine Durand-Gorde; Jocelyne Condo; Jean-Claude Deharo; Pierre Michelet; Emmanuel Fenouillet; Régis Guieu; Jean Ruf
Journal:  FEBS Open Bio       Date:  2012-11-17       Impact factor: 2.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.